1-12 of 12
Yingyi He
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Efficacy and Safety of Inaticabtagene Autoleucel in Children with Relapsed/Refractory (R/R) B-cell Acute Lymphoblastic Leukemia in China

Shiyuan Wang, Xiaoming Liu, Yongjun Fang, Kailin Xu, Hongsheng Zhou, Fei Li, Xianmin Guan, Yingyi He, Yi Feng, Lulu Lyu, Qunhui Peng, Xiaofan Zhu, Jianxiang Wang
Journal: Blood
Blood (2024) 144 (Supplement 1): 7200.
https://doi.org/10.1182/blood-2024-201125
Published: 2024
Journal Articles

A Multicenter Clinical Study of Cccg - APL-2017 in the Treatment of Children with Acute Promyelocytic Leukemia

Lixian Chang, Ju GAO, Xiaoying Lei, Yingyi He, Shuquan Zhuang, Chunhuai Li, Kaizhi Weng, Lingzhen Wang, Xia Guo, Qihui Liu, Pengfei Wang, Yong Zhuang, Mei Yan, Wei Liu, Hui Chen, Min Zhang, Shuhong Shen, Xiaofan Zhu, Xiuli Ju, Li Zhang, Zhuo Wang
Journal: Blood
Blood (2024) 144 (Supplement 1): 2899.
https://doi.org/10.1182/blood-2024-203264
Published: 2024
Journal Articles

Childhood AML Combined with AML1-ETO Fusion Gene and c-KIT or Other Mutations Had Favorable Survival Treated By the C-Huanan AML 2015 Protocol: Study in Multicenter of South of China

Xiaoqin Feng, Chunfu Li, Jian Li, Yongzhi Zheng, Mincui Zheng, Huirong Mai, Lihua Yang, Xiangling He, Yingyi He, Hong Wen, Yirong Li
Journal: Blood
Blood (2023) 142 (Supplement 1): 4291.
https://doi.org/10.1182/blood-2023-186587
Published: 2023
Journal Articles

Minimal Residual Disease after the 2 nd Induction Course Predicted Outcomes in Chinese Children with Acute Myeloid Leukaemia Treated According to the C-Huanan-AML 15 Protocol

Zheng Yong Zhi, Xiaoqin Feng, Chunfu Li, Mincui Zheng, Huirong Mai, Lihua Yang, Yingyi He, Xiangling He, Honggui Xu, Hong Wen, Jian Li, Jianda Hu
Journal: Blood
Blood (2022) 140 (Supplement 1): 9148–9149.
https://doi.org/10.1182/blood-2022-168409
Published: 2022
Journal Articles

A Comparison Study of Anti-CLL1 CART Cells Equipped with Different Co-Stimulatory Domains in the Treatment of Children with Refractory/Relapsed Acute Myeloid Leukemia

Kunlin PEI, Haoyu Xu, Peng-Fei Wang, Wenting Gan, Zhengbin HU, Yingyi He, Hui Zhang
Journal: Blood
Blood (2021) 138 (Supplement 1): 824.
https://doi.org/10.1182/blood-2021-146534
Published: 2021
Journal Articles

High EVI1 Expression Predict Adverse Outcome in Children with Acute Myeloid Leukemia: A Multicenter, Nonrandomized Clinical Study in China

Yongzhi Zheng, MD, Jian Li, MD, Xiaoqin Feng, Chunfu Li, MD, Mincui Zheng, Honggui Xu, Yingyi He, MD& PhD, Xiangling He, Jianda Hu, PhD
Journal: Blood
Blood (2020) 136 (Supplement 1): 37–38.
https://doi.org/10.1182/blood-2020-143312
Published: 2020
Journal Articles

Septicemia after Chemotherapy for Acute Lymphoblastic Leukemia: A Multicenter Study Chinese Children Cancer Group (CCCG)-ALL-2015

Chi Kong Li, MBBS, MD, Yiping Zhu, MD PhD, JingYan Tang, MD, Xiuli Ju, Runming Jin, MD, Ningling Wang, Yumei Chen, MD, Hui Jiang, PhD, Shaoyan Hu, MD PhD, Hu Liu, MD, Kaili Pan, PhD, Jiaoyang Cai, PhD, Yanjing Tang, PhD, Yingyi He, MD& PhD, Rong Yang, MD, Xiaowen Zhai, MD PhD, Lirong SUN, PhD, Yu Jie, MD
Journal: Blood
Blood (2019) 134 (Supplement_1): 5080.
https://doi.org/10.1182/blood-2019-123451
Published: 2019
Journal Articles

A Multicenter Nonrandom Clinical Study Using Induction Regimen of FLAG-IDA or Dae in Treatment of 101 Children with Newly Diagnosed CBF-AML in South of China: Clinical Responses and the Midterm Report of Survival

Xiaoqin Feng, Jian Li, MD, Chunfu Li, MD, Mincui Zheng, Honggui Xu, Yingyi He, MD& PhD, Changgang Li, MD, Hong Wen, Xiangling He, Lihua Yang, MD PhD
Journal: Blood
Blood (2019) 134 (Supplement_1): 3857.
https://doi.org/10.1182/blood-2019-126863
Published: 2019
Journal Articles

Effectiveness and Survival of 4 Courses of Chemotheray in 321 Children with Acute Myeloid Leukemia in China: A Multicenter, Nonrandomized Clinical Study

Zheng Yong Zhi, MD, Jian Li, MD, Xiaoqin Feng, Mincui Zheng, Chunfu Li, MD, Honggui Xu, Yingyi He, MD& PhD, Huirong Mai, Xiangling He, Lihua Yang, MD PhD, Hong Wen
Journal: Blood
Blood (2019) 134 (Supplement_1): 2596.
https://doi.org/10.1182/blood-2019-128375
Published: 2019
Journal Articles

ELN Genetic Risk Stratification Not Affect the Mid-Term Survival in Childhood AML: Report from Southern China Childhood AML Group

Xiaoqin Feng, PhD, Jian Li, MD, Xiangling He, Honggui Xu, Mincui Zheng, Hong Wen, Yingyi He, MD PhD, Sixi Liu, MD, Yongsheng Ruan, MD, Chunfu Li, MD
Journal: Blood
Blood (2018) 132 (Supplement 1): 5183.
https://doi.org/10.1182/blood-2018-99-118332
Published: 2018
Journal Articles

The Impact of Pain Control on Invasive Clinical Procedure on Children with Leukemia

Jiayi WANG, MD, Yingyi He, MD& PhD, Zhimin Liang, Tiezhen Ye, MD, Hui Zhang, PhD
Journal: Blood
Blood (2018) 132 (Supplement 1): 5827.
https://doi.org/10.1182/blood-2018-99-110088
Published: 2018
Journal Articles

Inherited NUDT15 Variants Substantially Increased Infection and Related Medical Cost in Children with Acute Lymphoblastic Leukemia

Jiabi Qian, M.Sc, Chuang Jiang, PhD, Qian Wenji, PhD, Wenge Hao, MD, Jiayi WANG, MD, Yingyi He, MD& PhD, Hua Jiang, MD, Yin Ting Cheung, PhD, Hui Zhang, PhD
Journal: Blood
Blood (2018) 132 (Supplement 1): 320.
https://doi.org/10.1182/blood-2018-99-114400
Published: 2018